Home › Funds › EARNEST PARTNERS LLC › CRL
EARNEST PARTNERS LLC position in CRL
CHARLES RIV LABS INTL INC · Health Care
EARNEST PARTNERS LLC reported holding 1,086,974 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$320.7M, representing 1.26% of its reported portfolio and ranking #12 among its reported holdings. EARNEST PARTNERS LLC has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EARNEST PARTNERS LLC's CRL position evolved
EARNEST PARTNERS LLC first disclosed a stake in CRL in Q3 2023 at 805,883 shares (US$157.9M). The position peaked in Q3 2026 at 1,086,974 shares, worth US$320.7M. Across 13 filings, EARNEST PARTNERS LLC increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,086,974 shares valued at US$320.7M — a reduction of -33,037 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 805.88K | $157.94M | New |
| Q4 2023 | 889.37K | $210.25M | Add |
| Q1 2024 | 893.76K | $242.16M | Hold |
| Q2 2024 | 1.00M | $207.51M | Add |
| Q3 2024 | 981.42K | $193.31M | Reduce |
| Q4 2024 | 982.15K | $181.31M | Hold |
| Q1 2025 | 1.00M | $151.21M | Add |
| Q2 2025 | 998.26K | $151.47M | Reduce |
| Q3 2025 | 1.01M | $157.51M | Add |
| Q4 2025 | 988.26K | $197.14M | Reduce |
| Q1 2026 | 971.37K | $167.56M | Reduce |
| Q2 2026 | 1.12M | $254.01M | Add |
| Q3 2026 | 1.09M | $320.67M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 28 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), Allspring Global Investments Holdings, LLC (US$254.6M), COOKE & BIELER LP (US$127.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- ARIEL INVESTMENTS, LLC 1.19M sh · $352.05M · Q3 2026
- Allspring Global Investments Holdings, LLC 887.52K sh · $254.57M · Q3 2026
- COOKE & BIELER LP 432.12K sh · $127.48M · Q3 2026
More on EARNEST PARTNERS LLC
FAQ
How long has EARNEST PARTNERS LLC held CRL?
EARNEST PARTNERS LLC has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EARNEST PARTNERS LLC's current position in CRL?
As of Q3 2026, EARNEST PARTNERS LLC holds 1.09M shares of CRL (CHARLES RIV LABS INTL INC), valued at $320.67M, representing 1.26% of its reported portfolio and ranking #12.
Has EARNEST PARTNERS LLC been buying or selling CRL?
In the latest 13F filing (Q3 2026), EARNEST PARTNERS LLC reduced its position in CRL. The position peaked in Q3 2026 at 1.09M shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, Allspring Global Investments Holdings, LLC, COOKE & BIELER LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.